PHA SCR nsp10 nsp16 methyltransferase
(Die Seite wurde neu angelegt: „{{up|PHA pharmacophore by screened target}} {{plb|((covid19+OR+covid-19+OR+sars-cov2+OR+sars-cov-2+OR+2019-ncov+OR+2019ncov))+AND+(nsp10+OR+non-structural+prot…“)
Zum nächsten Versionsunterschied →
Version vom 21. April 2021, 20:07 Uhr
| PHA pharmacophore by screened target |
| living current stringent pubmed readout on nsp10,16 methyltransferase |
32741322 2020. Identification of promising drug candidates against NSP16 of SARS-CoV-2 through computational drug repurposing study.
32835632 2020. In silico validation of coumarin derivatives as potential inhibitors against Main Protease, NSP10/NSP16-Methyltransferase, Phosphatase and Endoribonuclease of SARS CoV-2.
33252031 2020. Identification of naphthyridine and quinoline derivatives as potential Nsp16-Nsp10 inhibitors: a pharmacoinformatics study.
32738360 2020. Computational guided drug repurposing for targeting 2'-O-ribose methyltransferase of SARS-CoV-2.
33016237 2020. Structural analysis, virtual screening and molecular simulation to identify potential inhibitors targeting 2'-O-ribose methyltransferase of SARS-CoV-2 coronavirus.
